Immunodynamics of basiliximab in liver allograft recipient under continuous hemodiafiltration.
Eguchi
Susumu
S
Yanaga
Katsuhiko
K
Okudaira
Sadayuki
S
Miyamoto
Shungo
S
Itoh
Yuichiro
Y
Inuo
Hiroyuki
H
Yamanouchi
Kohsho
K
Hamada
Takayuki
T
Furui
Junichiro
J
Kanematsu
Takashi
T
D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000097:blood; D000077552:Basiliximab; D017583:Hemodiafiltration; D019698:Hepatitis C, Chronic / Q000601:surgery; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000097:blood; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D011993:Recombinant Fusion Proteins; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; D000077552:Basiliximab